OCEAN, said Albert, provides important risk-benefit data that doctors can now use in discussions with their patients. For ...
Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced its successful participation in the ...
The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...
Amazon S3 on MSN
What do Ozempic and Rollerblades have in common?
If you ask a random person on the street what they call weight loss drugs, odds are, they are going to say Ozempic. It is one ...
A new trial co-led by the Ottawa Heart Institute and the Research Institute of the McGill University Health Centre shows that ...
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today ...
A new trial co-led by the Ottawa Heart Institute and the Research Institute of the McGill University Health Centre shows that ...
MedPage Today on MSN
Major Trial Sours on Blanket DOAC Therapy After Successful Afib Ablation
OCEAN was an open-label trial conducted in Australia, Belgium, Canada, China, Germany, and Israel. Eligible participants had ...
The FDA approved darolutamide for mHSPC on June 3, [2025], so we now have this in our armamentarium, along with all the other ...
The world’s most widely used weedkiller is confronting legal battles as well as a cat-and-mouse game with nature. But it’s ...
People with type 2 diabetes who took low-dose aspirin were less likely to have a heart attack or stroke, University of ...
Efficacy of Icosapent Ethyl for Cardiovascular Risk Reduction by Aspirin Use in REDUCE-IT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback